In summary, the nomogram model integrating H-CTC count, L1CAM expression, and Ki-67 level demonstrates excellent accuracy and discriminative capability in predicting lymph node metastasis in BC, highlighting its promising clinical utility, particularly for preoperative individualized risk assessment and therapeutic decision-making. This evidence concerns the gene MKI67 and breast cancer.